Multimodal deep learning for Alzheimer’s disease dementia assessment

Shangran Qiu(Boston University), Matthew I. Miller(Boston University), Prajakta Joshi(Boston University), Joyce C. Lee(Boston University), Chonghua Xue(Boston University), Yunruo Ni(Boston University), Yuwei Wang(Boston University), Ileana De Anda‐Duran(Tulane University), Phillip H Hwang(Boston University), Justin Cramer(University of Nebraska Medical Center), Brigid Dwyer(Boston University), Honglin Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Michelle Kaku(Boston University), Sachin Kedar(Emory University), Peter H. Lee(Lahey Medical Center), Asim Mian(Boston University), Daniel L. Murman(University of Nebraska Medical Center), Sarah A. O’Shea(Boston University), Aaron B. Paul(Lahey Medical Center), Marie Saint‐Hilaire(Boston University), E. Alton Sartor(Boston University), Aneeta Saxena(Boston University), Ludy C. Shih(Boston University), Juan E. Small(Lahey Medical Center), Maximilian J. Smith(Lahey Medical Center), Arun Swaminathan(University of Nebraska Medical Center), Courtney Takahashi(Boston University), Olga Taraschenko(University of Nebraska Medical Center), Hui You(Chinese Academy of Medical Sciences & Peking Union Medical College), Jing Yuan(Chinese Academy of Medical Sciences & Peking Union Medical College), Yan Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuhan Zhu(Boston University), Michael L. Alosco(Boston University), Jesse Mez(Boston University), Thor D. Stein(Boston University), Kathleen L. Poston(Palo Alto University), Rhoda Au(Boston University), Vijaya B. Kolachalama(Boston University)
Nature Communications
June 20, 2022
Cited by 361Open Access
Full Text

Abstract

Worldwide, there are nearly 10 million new cases of dementia annually, of which Alzheimer's disease (AD) is the most common. New measures are needed to improve the diagnosis of individuals with cognitive impairment due to various etiologies. Here, we report a deep learning framework that accomplishes multiple diagnostic steps in successive fashion to identify persons with normal cognition (NC), mild cognitive impairment (MCI), AD, and non-AD dementias (nADD). We demonstrate a range of models capable of accepting flexible combinations of routinely collected clinical information, including demographics, medical history, neuropsychological testing, neuroimaging, and functional assessments. We then show that these frameworks compare favorably with the diagnostic accuracy of practicing neurologists and neuroradiologists. Lastly, we apply interpretability methods in computer vision to show that disease-specific patterns detected by our models track distinct patterns of degenerative changes throughout the brain and correspond closely with the presence of neuropathological lesions on autopsy. Our work demonstrates methodologies for validating computational predictions with established standards of medical diagnosis.


Related Papers

No related papers found

Powered by citation graph analysis